Shadi Tabibian: Navigating Modern Diagnosis and Individualized Care in Hemophilia A and B
Shadi Tabibian, Deputy of research at Blood Diseases Research Centers in Iran University of Medical Sciences, shared a post on LinkedIn about a recent article by Ming Y. Lim et al, published in Journal of Thrombosis and Haemostasis, adding:
“Hemophilia A and B: From Diagnosis to Personalized Lifelong Care.
The management of hemophilia has evolved dramatically—from conventional factor replacement to extended half-life concentrates, FVIII mimetics, rebalancing agents, and gene therapy.
This recent educational review provides a comprehensive overview of:
- The genetic and pathophysiological basis of hemophilia A and B
- Clinical presentation and laboratory diagnosis
- The expanding treatment landscape
- Treatment monitoring and inhibitor management
- Hemophilic arthropathy and age-related comorbidities
- The essential role of multidisciplinary and personalized care
Despite major therapeutic advances, important challenges remain.
Inhibitor development, progressive joint disease, laboratory monitoring of novel therapies, equitable treatment access, and the growing burden of cardiovascular and other age-related conditions continue to shape clinical practice.
The key message is clear: modern hemophilia care must extend beyond bleeding control.
It should aim to preserve joint health, reduce treatment burden, improve quality of life, and support individuals with hemophilia throughout their lifespan.”
Title: Diagnosis and management of hemophilia A and B
Authors: Ming Y. Lim, Jesús Ardila, Giancarlo Castaman, Yesim Dargaud, Karin Fijnvandraat, Roberta Gualtierotti, Cedric Hermans, Susan Shapiro
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?